☰

Matthew R. Rosebraugh, Ph.D. - Publications

Affiliations: 
2012 Pharmacy University of Iowa, Iowa City, IA 
Area:
Pharmacy, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Pang Y, Rosebraugh MR, Freise KJ, Parikh A, Mohamed MF. Are Clinical Therapeutic Protein-Drug Interaction Studies Needed When Disease Modification Is Driving the Potential Interaction? Journal of Clinical Pharmacology. PMID 30129669 DOI: 10.1002/Jcph.1290  0.454
2014 Rosebraugh MR, Widness JA, Nalbant D, Cress G, Veng-Pedersen P. Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants. Pediatric Research. 75: 336-42. PMID 24216541 DOI: 10.1038/Pr.2013.213  0.588
2013 Rosebraugh MR, Widness JA, Nalbant D, Veng-Pedersen P. A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia. Transfusion. 53: 1353-60. PMID 23033916 DOI: 10.1111/J.1537-2995.2012.03908.X  0.564
2012 Rosebraugh MR, Widness JA, Veng-Pedersen P. Multidose optimization simulation of erythropoietin treatment in preterm infants. Pediatric Research. 71: 332-7. PMID 22391632 DOI: 10.1038/Pr.2011.75  0.574
2011 Rosebraugh M, Widness JA, Veng-Pedersen P. Receptor-based dosing optimization of erythropoietin in juvenile sheep after phlebotomy. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 1214-20. PMID 21460232 DOI: 10.1124/Dmd.110.036855  0.475
Show low-probability matches.